Conference Roundup: AHSR 2026

Uptake of Take-Home Dosing of Methadone Among Medicaid Patients: An Analysis of Multi-State Medicaid Data

• Shashi Kapadia, MD, MS, Weill Cornell Medicine, CHERISH Research Affiliate, Presenter
• When: 3:00–4:30 PM MT, Individual Oral Session S1.1: Methadone Treatment, Retention & Take-Home Policy

Cost-Effectiveness of Contingency Management Adaptations for Co-Occurring Alcohol Use Disorder and Serious Mental Illness

• Sean Murphy, PhD, Weill Cornell Medicine, CHERISH Co-director, Presenter
• Danielle Ryan, MPH, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
• When: 3:00–4:30 PM MT, Individual Oral Session S1.2: Alcohol Screening, Treatment & Intervention

Impacts of state medical cannabis laws on substance use disorder and pain treatment among adults with chronic pain

• Beth McGinty, PhD, Weill Cornell Medicine, CHERISH Center & Policy Advisory Board Member, Presenter
• When: 3:00–4:30 PM MT, Individual Oral Session S1.3: Cannabis Policy, Use Patterns & Health Outcomes

Medicaid Payment and Billing Policies for Methadone Maintenance Treatment for Opioid Use Disorder, 2020-2025: A policy synthesis

• Yuhua Bao, PhD, Weill Cornell Medicine, CHERISH Pilot Grant, Training & Mentoring Core Director, Presenter
• When: 5:00–7:00 PM MT (Poster #6, presenting 6:00–7:00 PM)

A Microsimulation Modeling Platform to Inform Strategies for HCV Micro-elimination in Correctional Settings

• Zongbo Li, MPH, University of Minnesota, 2025-2026 CHERISH pilot grant recipient, Presenter
• When: 5:00–7:00 PM MT (Poster #13, presenting 5:00–6:00 PM)

Application of an Implementation Financing Strategies Compilation to School-Based Substance Use Prevention

• Andria Eisman, PhD, MPH, MS, Wayne State University, CHERISH Research Affiliate, Presenter
• When: 5:00–7:00 PM MT (Poster #27, presenting 5:00–6:00 PM)

Emergency Department-Substance Use Screening, Motivational Interviewing and Active Referral Targeting Substance Use Disorder and Overdose Prevention (ED-SMART): Randomized Controlled Trial Protocol

• Jennifer Brown, PhD, Purdue University, CHERISH Research Affiliate, Presenter
• When: 5:00–7:00 PM MT (Poster #40, presenting 6:00–7:00 PM)

Experiences and Evaluation of a Community Advisory Board with Substance Use Simulation Modeling

• Benjamin Linas, MD, MPH, Boston Medical Center, CHERISH Population Data & Modeling Core Director, Co-author
• Caroline Savitzky, MSW, Boston Medical Center, CHERISH Staff, Co-author
• Jocelyn Vititow, Boston Medical Center, CHERISH Staff, Co-author
• When: 5:00–7:00 PM MT (Poster #51, presenting 5:00–6:00 PM)

Association of continuous postpartum Medicaid eligibility with HCV linkage to care and treatment among persons with opioid use disorder

• Breanne Biondi, MPH, Boston University School of Public Health, 2024-2025 CHERISH pilot grant recipient, Presenter
• When: 5:00–7:00 PM MT (Poster #56, presenting 6:00–7:00 PM)

Medication for opioid use disorder initiation and discontinuation in pregnant and post-partum people in Massachusetts, 2014-2022

• Rachel Epstein, MD, MSc, Boston Medical Center, CHERISH Research Affiliate, Presenter
• When: 5:00–7:00 PM MT (Poster #59, presenting 5:00–6:00 PM)

Labor Cost Calculator for Assessing Staffing Costs: Application in Interagency Partnerships to Tackle Substance Use Disorders (SUDs)

• Don Lochana Ekanayake, MSc, University of Miami Miller School of Medicine, CHERISH Staff, Presenter
• When: 5:00–7:00 PM MT (Poster #70, presenting 6:00–7:00 PM)

Partisan divisions in support for local addiction residential treatment sites

• Breanne Biondi, MPH, Boston University School of Public Health, 2024-2025 CHERISH pilot grant recipient, Presenter
• When: 5:00–7:00 PM MT (Poster #72, presenting 6:00–7:00 PM)

↑ Back to Top

State-level variation in substance use-related Medicaid Section 1115 Waivers: a policy landscape analysis

• Sarah Gutkind, PhD, MSPH, Weill Cornell Medicine, 2025-2026 CHERISH pilot grant recipient, Presenter
• When: 9:45–11:15 AM MT, Individual Oral Session S2.2: Financing, Medicaid Innovation & Economic Evaluation of SUD Care

County- And State-Level Variation in Spending and Spending Effectiveness for Opioid Use Disorder in the United States, 2010–2019

• Bulat Idrisov, MD, MSc, University of Washington, 2023-2024 CHERISH pilot grant recipient, Presenter
• When: 9:45–11:15 AM MT, Individual Oral Session S2.2: Financing, Medicaid Innovation & Economic Evaluation of SUD Care

Economic Evaluation of Opioid Use Disorder Treatment Care Model in Primary Care: Evidence from the NIDA CTN-0074 PROUD Trial

• Ali Jalali, PhD, MA, Weill Cornell Medicine, CHERISH Methodology Core Co-director, Co-author
• Kai Yeung, PhD, PharmD, Kaiser Permanente Washington Health Research Institute, CHERISH Research Affiliate, Co-author
• Richard Nelson, PhD, University of Utah Spencer Fox Eccles School of Medicine, CHERISH Research Affiliate, Co-author
• Sean Murphy, PhD, Weill Cornell Medicine, CHERISH Co-director, Co-author
• Thanh Lu, PhD, RTI International, CHERISH Research Affiliate, Co-author
• When: 9:45–11:15 AM MT, Individual Oral Session S2.2: Financing, Medicaid Innovation & Economic Evaluation of SUD Care

Estimating the Impact of Medicaid-Funded Contingency Management on Treatment Retention: Evidence from California

• Brittany Bass, PhD, UCLA Integrated Substance Abuse Programs, CHERISH Research Affiliate, Presenter
• When: 9:45–11:15 AM MT, Individual Oral Session S2.2: Financing, Medicaid Innovation & Economic Evaluation of SUD Care

Cost-effectiveness of Providing Long-Acting Buprenorphine in Carceral Settings

• Zongbo Li, MPH, University of Minnesota, 2025-2026 CHERISH pilot grant recipient, Presenter
• When: 9:45–11:15 AM MT, Individual Oral Session S2.3: Addiction and the Criminal-Legal System

The CHERISH Cost Database: An Open, Standardized Resource for Cross-Study Comparison and Simulation Parameterization in Substance Use Disorder Treatment

• Yang Chen, MS, University of Miami Miller School of Medicine, CHERISH Staff, Presenter
• Danielle Ryan, MPH, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
• When: 1:15–2:45 PM MT, Individual Oral Session S3.3: Methods, Measurement & Evaluation in Addiction Health Services

Characterizing Unbalanced Panel Structures in NIDA-Funded Longitudinal Opioid Use Disorder Clinical Trials

• Ali Jalali, PhD, MA, Weill Cornell Medicine, CHERISH Methodology Core Co-director, Presenter
• When: 1:15–2:45 PM MT, Individual Oral Session S3.3: Methods, Measurement & Evaluation in Addiction Health Services

Ten Years of Health Economic Consultation for Substance Use Researchers: Growth, Geographic Expansion, and Sustained Impact

• Hamer Villamizar, MA, Weill Cornell Medicine, CHERISH Staff, Presenter
• When: 1:15–2:45 PM MT, Individual Oral Session S3.3: Methods, Measurement & Evaluation in Addiction Health Services

Estimated Impact of HR 1 Medicaid Work Requirements on Overdose Deaths and Costs

• Avik Chatterjee, MD, MPH, Boston Medical Center, 2026-2027 CHERISH pilot grant recipient, Presenter
• When: 3:00–4:30 PM MT, Individual Oral Session S4.1: Medicaid Policy and OUD Treatment Access

Telehealth Expansions Fail to Offset Reduced In-Person Substance Use Treatment Use In Medicaid, 2019-2022

• Beth McGinty, PhD, Weill Cornell Medicine, CHERISH Center & Policy Advisory Board Member, Presenter
• When: 3:00–4:30 PM MT, Individual Oral Session S4.2: Implementation Strategies, Adaptation, Dissemination & Practice Change

Trends in Hospital Admissions for Medetomidine Withdrawal in Philadelphia

• Margaret Lowenstein, MD, MSHP, University of Pennsylvania, Dissemination & Policy Core Co-director, Presenter
• When: 3:00–4:30 PM MT, Individual Oral Session S4.3: Opioid-Related Medical Comorbidity, Mortality & Emerging Risks

Injection drug-related endocarditis: Medications for opioid use disorder and association with mortality in a U.S. Medicaid sample

• Shashi Kapadia, MD, MS, Weill Cornell Medicine, CHERISH Research Affiliate, Presenter
• When: 3:00–4:30 PM MT, Individual Oral Session S4.3: Opioid-Related Medical Comorbidity, Mortality & Emerging Risks

A Coordinated Approach to Health Economic Evaluation in Criminal- Legal Settings: The JCOIN 2.0 CLEAR Protocol

• Ali Jalali, PhD, MA, Weill Cornell Medicine, CHERISH Methodology Core Co-director, Co-author
• Danielle Ryan, MPH, Weill Cornell Medicine, CHERISH Research Affiliate, Presenter
• Kathryn McCollister, PhD, University of Miami Miller School of Medicine, CHERISH Methodology Core Director, Co-author
• Paul Fishman, PhD, University of Washington School of Social Work, CHERISH Research Affiliate, Co-author
• Sean Murphy, PhD, Weill Cornell Medicine, CHERISH Co-director, Co-author
• When: 5:00–7:00 PM MT (Poster #24, presenting 6:00–7:00 PM)

Implementation Costs of Patient Navigation and Mobile Health Unit HIV and Opioid Use Disorder Services Delivery to Individuals Recently Released from Prison or Jail

• Czarina Behrends, PhD, MPH, Weill Cornell Medicine, CHERISH Research Affiliate, Co-author
• When: 5:00–7:00 PM MT (Poster #30, presenting 6:00–7:00 PM)

Linking Justice-Involved Individuals with Opioid Use Disorder to Primary Care Post-Release: Costs to Implement Transitions Clinic Network Post-Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS)

• Don Lochana Ekanayake, MSc, University of Miami Miller School of Medicine, CHERISH Staff, Presenter
• When: 5:00–7:00 PM MT (Poster #31, presenting 5:00–6:00 PM)

Mapping Microcosting Data to Evaluate Scalability, Transportability, Generalizability, and Sustainability: A Conceptual Framework for SUD Interventions

• Kathryn McCollister, PhD, University of Miami Miller School of Medicine, CHERISH Methodology Core Director, Presenter
• When: 5:00–7:00 PM MT (Poster #72, presenting 6:00–7:00 PM)

↑ Back to Top

Cannabis Use and Brain, Gut–Immune, and Quality of Life Outcomes in People Living With HIV

• Erminia Fardone, PhD, University of Miami Miller School of Medicine, CHERISH Staff, Presenter
• When: 8:00–10:00 AM MT (Poster #6, presenting 9:00–10:00 AM)

Caregiver Burden in Substance Use Disorders: A Scoping Review of Financial and Social Costs

• Erminia Fardone, PhD, University of Miami Miller School of Medicine, CHERISH Staff, Presenter
• When: 8:00–10:00 AM MT (Poster #58, presenting 8:00–9:00 AM)

Preferences for Injectable Medications for Opioid Use Disorder Among Recovery Housing Operators Based on Endorsement of Attitudinal and Capacity Barriers

• Rachel Winograd, PhD, University of Missouri-St. Louis, CHERISH Policy Advisory Board Member, Presenter
• When: 10:00–11:30 AM MT, Individual Oral Session S5.3: Peer, Recovery, Harm Reduction & Community-Based Service Models

Use of Peer Support Services for Substance Use Disorder in Medicaid by In-person and Telehealth Delivery, Care Setting, and Treatment Phase

• Beth McGinty, PhD, Weill Cornell Medicine, CHERISH Center & Policy Advisory Board Member, Presenter
• When: 10:00–11:30 AM MT, Individual Oral Session S5.3: Peer, Recovery, Harm Reduction & Community-Based Service Models

↑ Back to Top